Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant
GRAND RAPIDS, Mich., April 30, 2026 /PRNewswire/ -- Capitan Orthopedics, Inc. (https://capitanortho.com/) announced today that it has been granted Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its SupraSpacerTM implant. Today, over 2 million people a...
View original →